Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

• Despite strong earnings, Cardinal Health, Inc. reported a negative return on equity of 98.53% in the most recent quarter, which could signal underlying financial inefficiencies or significant debt levels that may concern risk-averse investors.
• Several institutional investors, including ProShare Advisors LLC and VestGen Advisors LLC, have recently reduced their stakes in the company, which may indicate a lack of confidence in the stock's near-term performance or a shift in investment strategy among key holders.
• Insiders, including CEO Jason Hollar, have sold a significant number of shares in recent months, with Hollar selling 80,000 shares in August, which could be interpreted as a signal that company leadership is taking advantage of the current high stock price to reduce their personal exposure.
• The company's revenue for the most recent quarter of $63.67 billion fell short of the consensus estimate of $65.15 billion, suggesting that while profitability is strong, top-line growth may be facing headwinds that could impact future earnings potential.
• Cardinal Health, Inc. has a relatively high price-to-earnings ratio of 35.23, which may be considered expensive compared to other healthcare stocks, potentially limiting upside if the company fails to sustain its current earnings growth trajectory.